Spatial Proteome Profiling with PSPro: Advancing Single-Cell-Type Resolution in Complex Tissues

Study Background and Research Question

Deciphering the molecular architecture of complex tissues remains a central challenge in spatial biology. Multicellular tissues, such as tumors and lymphoid organs, comprise diverse cell types arranged in intricate spatial patterns that underpin physiological and pathological processes. Traditional spatial proteomics methods, including laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging, have enabled mapping of protein expression in tissue slices, but trade-offs between spatial resolution, throughput, and depth of proteome coverage have persisted. To address these limitations, Mao et al. developed a novel approach—proximity labeling for spatial proteomics (PSPro)—to enable comprehensive, cell-type-resolved proteome profiling within intact tissue slices (reference study).

Key Innovation from the Reference Study

The central innovation of PSPro lies in its integration of antibody-targeted proximity biotinylation with efficient affinity purification. Unlike conventional antibody-based imaging, which is generally limited to a few markers, PSPro enables unbiased enrichment and identification of thousands of proteins from spatially defined cell populations in a single experiment. By fine-tuning labeling parameters, the method achieves high selectivity and proteome coverage, converting the traditional "antibody-epitope" detection paradigm to an "antibody-cell-type proteome" model. This all-at-once approach reveals spatial proteome heterogeneity underpinning tissue function and disease progression, particularly in complex environments such as pancreatic tumors and spleens.

Methods and Experimental Design Insights

PSPro employs a workflow that begins with the incubation of fixed tissue slices with cell-type-specific primary antibodies. These are detected using horseradish peroxidase (HRP)-conjugated secondary antibodies, which catalyze the localized deposition of biotin-phenol derivatives via tyramide signal amplification (TSA). The biotinylated proteins are then affinity-purified and subjected to quantitative mass spectrometry for proteome analysis. To further dissect spatial heterogeneity, the authors integrated laser microdissection (LMD) with PSPro, enabling precise isolation and comparative analysis of cell subpopulations from the same tissue section.

Protocol Parameters

• Tissue fixation: Formalin-fixed, paraffin-embedded or fresh-frozen sections are compatible, but fixation conditions must preserve antigenicity and protein integrity.
• Antibody incubation: Primary antibodies should be validated for specificity and optimal dilution to target cell types of interest.
• Tyramide-biotin labeling: HRP-conjugated secondary antibodies catalyze deposition of biotin-tyramide for 10–15 min at room temperature, with optimization required to balance labeling selectivity and background.
• Affinity purification: Streptavidin-based pulldown is used to enrich biotinylated proteins before MS.
• Laser microdissection (optional): LMD enables selection of specific regions or cell clusters for spatially resolved analysis.

These protocol elements are adapted from the reference study. Users should empirically optimize antibody concentrations, labeling durations, and tissue handling for each application.

Core Findings and Why They Matter

Applying PSPro to pancreatic tumor and spleen tissue slices, Mao et al. profiled the proteomes of ten distinct cell types within a single experiment, capturing thousands of proteins per cell type. Benchmarking against established methods—including flow cytometry- and LMD-based workflows—demonstrated reliable performance in terms of both selectivity and proteome depth. Notably, integrating LMD with PSPro enabled the authors to resolve spatial proteome heterogeneity within tumor slices, distinguishing cancer cell and immune cell subpopulations based on their molecular signatures. This ability to comprehensively map protein expression across multiple cell types, while maintaining spatial context, represents a substantial advance for studies of tissue organization, tumor microenvironments, and cellular interactions.

Comparison with Existing Internal Articles

Several internal resources discuss the technical underpinnings and practical advantages of tyramide signal amplification (TSA) in high-sensitivity detection workflows. For example, the article “Cy3 TSA Fluorescence System Kit: Amplifying Low-Abundance Detection” highlights the effectiveness of TSA-based methods for visualizing low-abundance biomolecules in immunohistochemistry (IHC), immunocytochemistry (ICC), and in situ hybridization (ISH). Similarly, “Cy3 TSA Fluorescence System Kit: Signal Amplification in...” details how tyramide-based amplification provides high-density, localized fluorescent signals for advanced fluorescence microscopy detection of proteins and nucleic acids.

While these internal articles focus primarily on fluorescence-based detection and signal amplification in imaging assays, the PSPro method extends the principle of localized tyramide-mediated labeling into the proteomics domain. By coupling TSA chemistry with mass spectrometry-based proteome analysis, PSPro bridges the gap between sensitive biomolecule detection and unbiased, multiplexed proteomic profiling. This integration offers a conceptual and technical advance over single-marker imaging, providing deeper insights into tissue heterogeneity and molecular regulation.

Limitations and Transferability

Despite its strengths, PSPro has several limitations. The approach relies on the availability of highly specific antibodies for cell-type targeting, and labeling efficiency can vary depending on tissue type, fixation, and antigen accessibility. The authors note that optimization of labeling parameters is critical to minimize background and maximize selectivity. Additionally, while the method enables broad proteome coverage, it may not detect extremely low-abundance proteins without further amplification or enrichment. Transferability to other tissue types and disease models is promising but requires validation of antibody specificity, compatibility with tissue preparation methods, and adaptation of affinity purification strategies.

Research Support Resources

Researchers aiming to implement or adapt TSA-based signal amplification in their own workflows can benefit from robust, validated reagent systems. The Cy3 TSA Fluorescence System Kit (SKU K1051) from APExBIO provides a standardized platform for sensitive fluorescence-based detection in IHC, ICC, and ISH. This kit leverages HRP-mediated tyramide deposition to achieve high-density, localized signal amplification, facilitating the detection of low-abundance proteins and nucleic acids in fixed cells and tissues. While originally designed for fluorescence microscopy, components such as HRP-conjugated secondary antibodies and tyramide reagents are directly relevant for adapting proximity labeling workflows akin to PSPro, supporting the broader application of signal amplification in spatial proteomics and advanced biomolecule detection pipelines.